Mr. Miao has advised on numerous equity and debt capital market transactions involving corporate issuers and international underwriters, including global offerings and listings and bond offerings on the Hong Kong Stock Exchange and initial public offerings and secondary offerings registered with the U.S. Securities and Exchange Commission. Mr. Miao has advised clients on mergers and acquisitions, restructurings, as well as acquisitions of listed companies. Mr. Miao has also advised on Hong Kong-listed company compliance and corporate governance.
Mr. Miao has been involved in Hong Kong listing projects across the industries of biotechnology, TMT, clean energy, consumer, mining, real estate and financial services etc. Before establishing Han Kun's Hong Kong office, Mr. Miao practiced law for many years with leading international law firms, such as Latham & Watkins and Morrison & Foerster. Prior to joining the legal profession, Mr. Miao worked for leading international pharmaceutical, healthcare, and life sciences companies, such as GlaxoSmithKline Plc and Eli Lilly and Company.
Mr. Miao has professional expertise and practical experiences in licence applications for carrying out multiple regulated activities with the Securities and Futures Commission of Hong Kong and the Hong Kong Monetary Authority. He served as associate general counsel for American International Assurance, a multinational insurance company. Mr. Miao is also a corporate finance specialist recognized by the Hong Kong Securities Institute.
